We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.52B
AUM Growth
+$35M
Cap. Flow
+$831M
Cap. Flow %
23.65%
Top 10 Hldgs %
38.14%
Holding
2,292
New
549
Increased
398
Reduced
416
Closed
501
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHCAU
2126
DELISTED
DHC Acquisition Corp. Unit
DHCAU
-24,700
Closed -$243K
ALTU
2127
DELISTED
Altitude Acquisition Corp
ALTU
-12,800
Closed -$127K
ESACU
2128
DELISTED
ESGEN Acquisition Corporation Unit
ESACU
-10,000
Closed -$101K
LBBBU
2129
DELISTED
Lakeshore Acquisition II Corp. Unit
LBBBU
-55,746
Closed -$560K
FAZE
2130
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
-10,000
Closed -$99K
ROVR
2131
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-17,963
Closed -$104K
NSTG
2132
DELISTED
NanoString Technologies, Inc.
NSTG
-13,912
Closed -$483K
NCACW
2133
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
-11,300
Closed -$3K
NCAC
2134
DELISTED
Newcourt Acquisition Corp Class A Ordinary Share
NCAC
-22,600
Closed -$226K
SLGC
2135
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-11,134
Closed -$89K
FTCH
2136
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-22,300
Closed -$337K
FRXB
2137
DELISTED
Forest Road Acquisition Corp. II
FRXB
-50,043
Closed -$489K
CFIV
2138
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
-58,568
Closed -$575K
SUAC
2139
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
-21,900
Closed -$216K
PACW
2140
DELISTED
PacWest Bancorp
PACW
-51,953
Closed -$2.24M
ALOR
2141
DELISTED
ALSP Orchid Acquisition Corp I
ALOR
-50,000
Closed -$499K
EQRX
2142
DELISTED
EQRx, Inc. Common Stock
EQRX
-19,167
Closed -$79K
NXGN
2143
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-28,501
Closed -$596K
AAC.U
2144
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
-21,930
Closed -$217K
TRHC
2145
CALL
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-29,700
Closed -$171K
TRHC
2146
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-19,300
Closed -$111K
TRHC
2147
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-19,300
Closed -$111K
NFNT
2148
DELISTED
Infinite Acquisition Corp.
NFNT
-50,000
Closed -$494K
CCV.U
2149
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
-21,909
Closed -$218K
RAD
2150
PUT
DELISTED
Rite Aid Corporation
RAD
-40,000
Closed -$350K

Similar funds

Prelude Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Prelude Capital Management held 2,292 positions worth $3.52B, up 1% from $3.48B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Prelude Capital Management deployed $831M of net new capital in Q2 2022, opening 549 new positions and adding to 398 existing holdings. Its largest new stake was SM Energy: 2,001,257 shares worth $1.94M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was TSMC, an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q2 2022 buy was SM Energy: 2,001,257 shares worth $1.94M.
  • Prelude Capital Management added most to Lockheed Martin in Q2 2022, an estimated $85.8M increase.
  • Prelude Capital Management's biggest Q2 2022 reduction was TSMC, cutting an estimated $13.2M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q2 2022, selling an estimated $42M.
  • Prelude Capital Management's ten largest holdings make up 38% of its $3.52B portfolio in Q2 2022.
  • Prelude Capital Management opened 549 new positions and closed 501 in Q2 2022.
  • Prelude Capital Management's portfolio value rose 1% quarter-over-quarter to $3.52B.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.